Abbvie S.R.O. is the Czech subsidiary of AbbVie, a global research driven biopharmaceutical company. It focuses on the registration, marketing, medical support and market access of innovative prescription medicines in the Czech Republic, while utilising AbbVie's global research, development and manufacturing capabilities. Its therapeutic portfolio covers key areas such as immunology, oncology, neuroscience, virology, eye care and medical aesthetics, with a combination of originator medicines and biologic therapies. Abbvie S.R.O. cooperates closely with healthcare professionals, hospitals, clinics and payers, supports clinical research activities and patient education, and provides medical and scientific information. Strategically, the company positions itself as a partner to the Czech healthcare system delivering innovative therapies for serious chronic and life threatening diseases with an emphasis on improving patient outcomes and access to modern treatment.
Headquarters
Bucharova 2817/13
Prague; The City of Prague;
Postal Code: 15800
Contact Details: Purchase the Abbvie S.R.O. report to view the information.
Website: http://www.abbvie.cz
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service